Found: 15
Select item for more details and to access through your institution.
Elimination of contaminating cap genes in AAV vector virions reduces immune responses and improves transgene expression in a canine gene therapy model.
- Published in:
- Gene Therapy, 2014, v. 21, n. 4, p. 363, doi. 10.1038/gt.2014.4
- By:
- Publication type:
- Article
Intragenic integration in DLC1 sustains factor VIII expression in primary human cells without insertional oncogenicity.
- Published in:
- Gene Therapy, 2014, v. 21, n. 4, p. 402, doi. 10.1038/gt.2014.11
- By:
- Publication type:
- Article
Sonic hedgehog gene therapy increases the ability of the dystrophic skeletal muscle to regenerate after injury.
- Published in:
- Gene Therapy, 2014, v. 21, n. 4, p. 413, doi. 10.1038/gt.2014.13
- By:
- Publication type:
- Article
Long-term in vivo imaging of translated RNAs for gene therapy.
- Published in:
- Gene Therapy, 2014, v. 21, n. 4, p. 434, doi. 10.1038/gt.2013.89
- By:
- Publication type:
- Article
Calpain-dependent clearance of the autophagy protein p62/SQSTM1 is a contributor to ΔPK oncolytic activity in melanoma.
- Published in:
- Gene Therapy, 2014, v. 21, n. 4, p. 371, doi. 10.1038/gt.2014.6
- By:
- Publication type:
- Article
Gene therapy for trigeminal pain in mice.
- Published in:
- Gene Therapy, 2014, v. 21, n. 4, p. 422, doi. 10.1038/gt.2014.14
- By:
- Publication type:
- Article
An integration-defective lentivirus-based resource for site-specific targeting of an edited safe-harbour locus in the human genome.
- Published in:
- Gene Therapy, 2014, v. 21, n. 4, p. 343, doi. 10.1038/gt.2014.1
- By:
- Publication type:
- Article
Long-term correction of biochemical and neurological abnormalities in MLD mice model by neonatal systemic injection of an AAV serotype 9 vector.
- Published in:
- Gene Therapy, 2014, v. 21, n. 4, p. 427, doi. 10.1038/gt.2014.17
- By:
- Publication type:
- Article
Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer.
- Published in:
- Gene Therapy, 2014, v. 21, n. 4, p. 393, doi. 10.1038/gt.2014.10
- By:
- Publication type:
- Article
Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood.
- Published in:
- Gene Therapy, 2014, v. 21, n. 4, p. 440, doi. 10.1038/gt.2014.2
- By:
- Publication type:
- Article
Effect of bortezomib on the efficacy of AAV9.SERCA2a treatment to preserve cardiac function in a rat pressure-overload model of heart failure.
- Published in:
- Gene Therapy, 2014, v. 21, n. 4, p. 379, doi. 10.1038/gt.2014.7
- By:
- Publication type:
- Article
Gene transfer of arginine kinase to skeletal muscle using adeno-associated virus.
- Published in:
- Gene Therapy, 2014, v. 21, n. 4, p. 387, doi. 10.1038/gt.2014.9
- By:
- Publication type:
- Article
Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors.
- Published in:
- Gene Therapy, 2014, v. 21, n. 4, p. 450, doi. 10.1038/gt.2014.8
- By:
- Publication type:
- Article
A macrophage-specific synthetic promoter for therapeutic application of adiponectin.
- Published in:
- Gene Therapy, 2014, v. 21, n. 4, p. 353, doi. 10.1038/gt.2014.3
- By:
- Publication type:
- Article
Efficient delivery of lentiviral vectors into resting human CD4 T cells.
- Published in:
- Gene Therapy, 2014, v. 21, n. 4, p. 444, doi. 10.1038/gt.2014.5
- By:
- Publication type:
- Article